557 data "https:" "https:" "https:" "https:" "I.E" "UCL" "UCL" positions at McGill University
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
have an active job in Workday > applies as an External Candidate Note: Review the information found here before you apply as external https://www.mcgill.ca/hr/files/hr
-
semester. AVAILABLE POSITIONS FOR: NUR3 653: SSSP NUR3 658: SSSP NUR3 673: Lab Facilitator DEADLINE TO APPLY IS MARCH 20, 2026. For details job descriptions and information regarding TQRs, please visit
-
TO APPLY IS MARCH 6, 2026, inclusively. For details job descriptions and information regarding TQRs, please visit: https://www.mcgill.ca/nursing/about/employment-opportunities HOW TO APPLY: Internal
-
communities. Additional Information: Effective dates of the appointment are April 27 - June 19, 2026. Course dates are May 11 - June 5, 2026. This course will be offered in-person in Sheshatshiu & Natuashish
-
more information about the eligibility for promotion and reappointment, please consult the following link: https://www.mcgill.ca/apo/academic-life-cycle/contract-academic-staff-cas/ranked-cas Faculty
-
pelvic) anatomy using pre-dissected cadaveric specimens (i.e., prosections). In addition, UCAs will be expected to participate in laboratory set-up, clean-up, and reinforcing the Anatomy Lab Code
-
position is based in the McGill Engineering Student Centre (MESC), supporting the Software Engineering Co-op Program (https://www.mcgill.ca/ece/undergrad/information/software-engineering-co-op ). Position
-
involves acquisition of behavioural and MRI brain imaging data in Toronto from older adults participating in a personalized intervention to lower the risk of dementia. The primary objective of the position
-
. Additional Information: Effective dates of the appointment are April 23 - June 5, 2026. Course dates are May 4 - 28, 2026. This course will be offered in-person in Gesgapegiag following the schedule above. You
-
at Montreal Neurological Institute-Hospital (The Neuro; McGill University) aims to validate tests (biomarkers) to identify the presence of age-related diseases (i.e., Alzheimer’s disease) before the symptom